Inventor

James Marvin Veal

Inventor

Apex, NC, US

Overview

2001–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 96 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds36%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%

A61KPreparations for medical, dental or toiletry purposes22%

C07BGeneral methods of organic chemistry3%

Y02ATechnologies for adaptation to climate change2%

A61NElectrotherapy2%

C40BCombinatorial chemistry1%

PatentTitleYear

11,084,793Inhibitors of lysine specific demethylase-12021 11,040,985Chemical compounds as inhibitors of interleukin-1 activity2021 11,028,066Inhibitors of lysine specific demethylase-12021 10,870,634Histone demethylase inhibitors2020 10,864,202Inhibitors of lysine specific demethylase-12020 10,815,234Histone demethylase inhibitors2020 10,807,956Histone demethylase inhibitors2020 10,807,982Bromodomain inhibitors2020 10,703,739Compositions comprising an inhibitor of lysine specific demethylase-12020 10,702,517Bromodomain inhibitor2020 10,654,830Histone demethylase inhibitors2020 10,654,810Inhibitors of lysine specific demethylase-12020 10,626,103Inhibitor of lysine specific demethylase-12020 10,626,104Inhibitors of lysine specific demethylase-12020 10,611,763Histone demethylase inhibitors2020 10,597,365Histone demethylase inhibitors2020 10,597,376Inhibitors of lysine specific demethylase-12020 10,543,198Inhibitor of lysine specific demethylase-12020 10,526,327Histone demethylase inhibitors2020 10,494,371Bromodomain inhibitors2019 10,414,750Inhibitors of lysine specific demethylase-12019 10,385,051Inhibitors of lysine specific demethylase-12019 10,336,727Histone demethylase inhibitors2019 10,316,016Compositions comprising an inhibitor of lysine specific demethylase-12019 10,273,222Histone demethylase inhibitors2019 10,208,039Histone demethylase inhibitors2019 10,207,999Inhibitors of lysine specific demethylase-12019 10,202,381Histone demethylase inhibitors2019 10,202,360Therapeutic compounds2019 10,179,769Histone demethylase inhibitors2019 10,174,003Histone demethylase inhibitors2019 10,173,996Histone demethylase inhibitors2019 10,150,754Histone demethylase inhibitors2018 10,131,664Inhibitors of lysine specific demethylase-12018 10,112,940Histone demethylase inhibitors2018 10,100,046Inhibitors of lysine specific demethylase-12018 10,071,984Histone demethylase inhibitors2018 10,047,069Compositions comprising an inhibitor of lysine specific demethylase-12018 10,040,779Histone demethylase inhibitors2018 10,030,017Histone demethylase inhibitors2018 10,023,543Inhibitors of lysine specific demethylase-12018 10,011,583Inhibitors of lysine specific demethylase-12018 9,994,562Histone demethylase inhibitors2018 9,963,441Histone demethylase inhibitors2018 9,944,636Inhibitors of lysine specific demethylase-12018 9,908,865'Histone demethylase inhibitors'2018 9,908,885'Bromodomain inhibitors'2018 9,902,719'Inhibitors of lysine specific demethylase-1'2018 9,896,436'Histone demethylase inhibitors'2018 9,828,358Compositions comprising an inhibitor of lysine specific demethylase-12017 9,828,343Histone demethylase inhibitors2017 9,822,119'Inhibitors of lysine specific demethylase-1'2017 9,776,974'Inhibitors of lysine specific demethylase-1'2017 9,771,329'Inhibitors of lysine specific demethylase-1'2017 9,725,441'Histone demethylase inhibitors'2017 9,714,230'Histone demethylase inhibitors'2017 9,701,657'Histone demethylase inhibitors'2017 9,676,770'Histone demethylase inhibitors'2017 9,656,956'Benzene, pyridine, and pyridazine derivatives'2017 9,643,965'Histone demethylase inhibitors'2017 9,617,242'Histone demethylase inhibitors'2017 9,611,221'Histone demethylase inhibitors'2017 9,604,961'Histone demethylase inhibitors'2017 9,573,930'Inhibitors of lysine specific demethylase-1'2017 9,527,829'Histone demethylase inhibitors'2016 9,458,129'Histone demethylase inhibitors'2016 9,447,045'Histone demethylase inhibitors'2016 9,255,097'Inhibitors of lysine specific demethylase-1'2016 9,133,166'Histone demethylase inhibitors'2015 9,107,916'Histone demethylase inhibitors'2015 9,085,534'Histone demethylase inhibitors'2015 9,034,900'Bromodomain inhibitors'2015 8,987,461'Histone demethylase inhibitors'2015 8,969,343'Histone demethylase inhibitors'2015 8,952,151'Histone demethylase inhibitors'2015 8,871,767'2-arylimidazo[1,2-B]pyridazine, 2-phenylimidazo[1,2-A]pyridine, and 2-phenylimidazo[1,2-A]pyrazine derivatives'2014 8,309,548'Benzene, pyridine, and pyridazine derivatives'2012 8,114,885'Chemical compounds'2012 7,928,135'Benzene, pyridine, and pyridazine derivatives'2011 7,906,529'Benzene, pyridine, and pyridazine derivatives'2011 7,858,626'Pyrimidineamines as angiogenesis modulators'2010 7,678,803'Quinazoline derivatives for the treatment of cancer'2010 7,459,455'Pyrimidine compounds'2008 7,358,370'Benzene, pyridine, and pyridazine derivatives'2008 7,279,473'Pyrazolopyridazine derivatives'2007 7,262,203'Pyrimidineamines as angiogenesis modulators'2007 7,238,813'Chemical compounds'2007 7,166,597'Fused pyrazole derivatives being protein kinase inhibitors'2007 7,105,529'Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects'2006 7,105,530'Pyrimidineamines as angiogenesis modulators'2006 6,815,439'Substituted aza-oxindole derivatives'2004 6,624,171'Substituted aza-oxindole derivatives'2003 6,541,503'Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors'2003 6,387,919'Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors'2002 6,369,086'Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors'2002 6,268,391'Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2021Based in Apex, NC, US· patent location history

2002–2008Patents assigned to SMITHKLINE BEECHAM CORP (10)· patent assignee history

2002Based in Cary, NC, US· patent location history

2003–2007Based in Durham, NC, US· patent location history

2007Based in Research Triangle Park, NC, US· patent location history

2008–2012Patents assigned to SERENEX INC (5)· patent assignee history

2015–2018Patents assigned to QUANTICEL PHARMACEUTICALS INC (16)· patent assignee history

2016–2021Patents assigned to CELGENE QUANTICEL RES INC (64)· patent assignee history

2017Patents assigned to CELGENE QUANTICAL RES INC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CELGENE QUANTICEL RES INC	64	2016–2021
QUANTICEL PHARMACEUTICALS INC	16	2015–2018
SMITHKLINE BEECHAM CORP	10	2002–2008
SERENEX INC	5	2008–2012
CELGENE QUANTICAL RES INC	2	2017

Locations

Location	Patents	Span
Apex, NC, US	89	2001–2021
Durham, NC, US	5	2003–2007
Research Triangle Park, NC, US	1	2007
Cary, NC, US	1	2002